Beam sues 2 biotechs, alleging theft of base editing trade secrets

AI Summary

Beam Therapeutics is suing two biotechnology companies, alleging that a former scientist took confidential base-editing information and helped develop a competing rare-disease treatment at YolTech Therapeutics. Serapha Bio, which licensed the therapy, denies the allegations.

Beam claimed a former scientist stole confidential information and quietly spun up a rival rare disease treatment at YolTech Therapeutics. Serapha Bio, which licensed that therapy, denies the charges.